← ANALYSTS · TIPRANKS

Sami Corwin · William Blair

#511among 12,504 TipRanks analysts★★★★★★★★★★
Hits 55% 167 of 301 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +18.5% Over a year after the rating, TipRanks’ measure
Our companies rated now 12 Buy / hold / sell: 10 / 2 / 0
Upside of the analyst’s targets — Average over 0 current targets, to the last price
The market’s answer to the ratings — No upgrade, downgrade or target change with a known move yet
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Sep 18on TipRanks 02:55 RAREIWMUltragenyx Pharmaceutical · $1.5B Reiterated Hold — — −0.1%next day −0.6% · 5 days −1.3%
Sep 9on TipRanks 10:55 TYRAIWMTyra Bioscience · $1.3B Reiterated Buy — — −17.2%next day +7.6% · 5 days +11.7%
Sep 8on TipRanks 10:55 BEAMIWMBeam Therapeutics · $2.6B Reiterated Buy — — −9.0%next day −5.7% · 5 days −12.3%
Aug 31on TipRanks 10:55 BMRNBioMarin Pharmaceutical · $10.8B Reiterated Hold — — +1.2%next day +0.1% · 5 days −0.8%
Aug 28on TipRanks 15:25 CRSPIWMCrispr Therapeutics AG · $5.0B Reiterated Buy — — −2.6%next day −1.0% · 5 days −3.5%
Aug 13on TipRanks 12:55 CABAIWMCabaletta Bio · $275M Reiterated Buy — — −5.6%next day +1.7% · 5 days +19.7%
Aug 13on TipRanks 04:55 ALLOIWMAllogene Therapeutics · $463M Reiterated Buy — — −5.0%next day +3.7% · 5 days +8.0%
Aug 11on TipRanks 19:15 NGNEIWMNeurogene · $479M Reiterated Buy — — +3.0%next day −4.3% · 5 days +7.1%
Aug 6on TipRanks 22:31 SLDBIWMSolid Biosciences · $615M Reiterated Buy — — −4.3%next day +2.1% · 5 days +9.3%
Aug 6on TipRanks 03:15 TNYATenaya Therapeutics · $126M Reiterated Buy — — −7.4%next day −0.5% · 5 days −0.1%
Aug 3on TipRanks 11:55 KRYSIWMKrystal Biotech · $9.8B Reiterated Buy — — −9.8%next day +2.1% · 5 days +4.1%
Feb 20on TipRanks 04:55 PTCTIWMPTC Therapeutics · $5.1B Reiterated Buy — — +0.4%next day +0.8% · 5 days −3.0%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗